Download Files:
Medroxalol
SKU
HY-101656-10 mg
Category Reference compound
Tags Adrenergic Receptor, Cardiovascular Disease, GPCR/G Protein;Neuronal Signaling
$750 – $5,950
Products Details
Product Description
– Medroxalol (RMI81968) is an orally active adrenergic receptor antagonist, blocks α- and β-adrenergic receptors. Medroxalol shows antihypertensive and vasodilating effects[1].
Web ID
– HY-101656
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– Neuroscience-Neuromodulation
Molecular Formula
– C20H24N2O5
References
– [1]Dage RC, et al. Cardiovascular properties of medroxalol, a new antihypertensive drug. J Cardiovasc Pharmacol. 1981 Mar-Apr;3(2):299-315.
CAS Number
– 56290-94-9
Molecular Weight
– 372.41
Compound Purity
– 99.66
SMILES
– O=C(N)C1=CC(C(O)CNC(C)CCC2=CC=C(OCO3)C3=C2)=CC=C1O
Clinical Information
– No Development Reported
Research Area
– Cardiovascular Disease
Solubility
– DMSO : 50 mg/mL (ultrasonic)
Target
– Adrenergic Receptor
Pathway
– GPCR/G Protein;Neuronal Signaling
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.